An open, single-arm, single-centre,Phase II clinical study evaluating Cadonilimab in combination with Ramucirumab for the treatment of advanced hepatocellular carcinoma that has failed at systemic therapy
To evaluate the efficacy Cadonilimab in combination with Ramucirumab for the treatment of advanced Hepatocellular Carcinoma that has failed at systemic therapy